Nbt Bank N A Bristol Myers Squibb CO Transaction History

Nbt Bank N A

$1.47 Billion
Q3 2024

A detailed history of Nbt Bank N A transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nbt Bank N A holds 81,139 shares of BMY stock, worth $4.69 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

81,139

Previous 88,160 7.96%

Holding current value

$4.69 Million

Previous $3.66 Million 14.67%

% of portfolio

0.29%

Previous 0.26%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $278,452 - $363,336	-7,021 Reduced 7.96%	81,139 $4.2 Million
Q2 2024 Jul 30, 2024	SELL	$40.25 - $52.99 $241,942 - $318,522	-6,011 Reduced 6.38%	88,160 $3.66 Million
Q1 2024 Apr 24, 2024	SELL	$47.98 - $54.4 $212,887 - $241,372	-4,437 Reduced 4.5%	94,171 $5.11 Million
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $23,997 - $28,635	-495 Reduced 0.5%	98,608 $5.06 Million
Q3 2023 Oct 26, 2023	BUY	$57.89 - $64.73 $864,876 - $967,066	14,940 Added 17.75%	99,103 $5.75 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $188,071 - $208,824	-2,952 Reduced 3.39%	84,163 $5.38 Million
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $70,441 - $79,896	-1,072 Reduced 1.22%	87,115 $6.04 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $91,215 - $108,011	-1,332 Reduced 1.49%	88,187 $6.34 Million
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $62 - $36,960	-481 Reduced 0.53%	89,519 $6.36 Million
Q2 2022 Jul 26, 2022	SELL	$72.62 - $79.98 $8,496 - $9,357	-117 Reduced 0.13%	90,000 $6.93 Million
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $203,129 - $243,570	-3,304 Reduced 3.54%	90,117 $6.58 Million
Q4 2021 Jan 27, 2022	SELL	$53.63 - $62.52 $268,150 - $312,600	-5,000 Reduced 5.08%	93,421 $5.82 Million
Q3 2021 Oct 18, 2021	SELL	$59.17 - $69.31 $47,927 - $56,141	-810 Reduced 0.82%	98,421 $5.82 Million
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $51,509 - $56,093	-832 Reduced 0.83%	99,231 $6.63 Million
Q1 2021 Apr 08, 2021	SELL	$59.34 - $66.74 $254,865 - $286,648	-4,295 Reduced 4.12%	100,063 $6.32 Million
Q4 2020 Jan 15, 2021	SELL	$57.74 - $65.43 $568,623 - $644,354	-9,848 Reduced 8.62%	104,358 $6.47 Million
Q3 2020 Oct 29, 2020	BUY	$57.43 - $63.64 $585,613 - $648,937	10,197 Added 9.8%	114,206 $6.89 Million
Q2 2020 Jul 22, 2020	SELL	$54.82 - $64.09 $220,924 - $258,282	-4,030 Reduced 3.73%	104,009 $6.12 Million
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $118,784 - $172,620	-2,560 Reduced 2.31%	108,039 $6.02 Million
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $334,726 - $436,620	6,802 Added 6.55%	110,599 $7.1 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $67,448 - $79,969	-1,577 Reduced 1.5%	103,797 $5.26 Million
Q2 2019 Aug 07, 2019	BUY	$44.62 - $49.34 $85,001 - $93,992	1,905 Added 1.84%	105,374 $4.78 Million
Q1 2019 May 06, 2019	BUY	$45.12 - $53.8 $62,942 - $75,051	1,395 Added 1.37%	103,469 $4.94 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $127,409 - $165,219	2,613 Added 2.63%	102,074 $5.31 Million
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $118,658 - $133,837	-2,150 Reduced 2.12%	99,461 $6.18 Million
Q2 2018 Jul 31, 2018	SELL	$50.53 - $62.98 $161,039 - $200,717	-3,187 Reduced 3.04%	101,611 $5.62 Million
Q1 2018 May 22, 2018	SELL	$59.92 - $68.98 $227,036 - $261,365	-3,789 Reduced 3.49%	104,798 $6.63 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $596,462 - $650,297	-9,951 Reduced 8.39%	108,587 $6.65 Million
Q3 2017 Nov 07, 2017	SELL	$55.23 - $63.74 $76,438 - $88,216	-1,384 Reduced 1.15%	118,538 $7.56 Million
Q2 2017 Aug 08, 2017	BUY	N/A	119,922	119,922 $6.68 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbt Bank N A , based on Form 13F filings with the SEC.

News

Stay updated on Nbt Bank N A with notifications on news.

Account